이가희 교수
Yi, K H
서울대학교 내과 · 의학
연구실 소개
이가희 교수의 연구실은 갑상선암의 진단 및 치료 전략에 중점을 두고 있으며, 특히 고해상도 초음파를 통한 갑상선 결절 조기 발견과 그로 인한 갑상선암 유병률 증가 현상에 대한 원인 분석을 수행하고 있습니다. 또한 TERT 프로모터 돌연변이, BRAF 및 RAS 유전자 변이와 같은 분자적 생물학적 특성과 갑상선암의 예후 간의 연관성을 규명하고자 하며, 장기적인 생존율 및 전이 패tern 분석을 통해 개인 맞춤형 치료 전략 수립에 기여하고자 합니다. 특히, 활성 관찰 전략과 수술 치료의 적정성에 대한 임상적 근거를 마련하는 데에도 주력하고 있습니다.
연구 현황
연구 성과 추이
표시된 성과는 수집된 데이터 기준으로 산출되며, 일부 차이가 있을 수 있습니다.
주요 논문
15The incidence of thyroid cancer has rapidly increased, with a decrease in tumors of large size, LN involvement, and ETE, although the decreasing rates of LN involvement and ETE were not as prominent as decreasing rates of large size tumors. The mortality and recurrence rates have also decreased. Future long-term follow-up of patients diagnosed in the most recent decade is needed to confirm the prognostic characteristics of Korean PTC patients.
BACKGROUND: Recent reports suggest that mutations in the promoter of the gene encoding telomerase reverse transcriptase (TERT) affect thyroid cancer outcomes. METHODS: In all, 551 patients with differentiated thyroid cancer (DTC) enrolled in this study. The median follow-up duration was 4.8 years (interquartile range, 3.4-10.6 years). RESULTS: TERT promoter mutations were detected in 25 DTCs (4.5%): 2.8% in neither BRAF-mutated nor RAS-mutated tumors, 4.8% in BRAF-mutated tumors, and 11.3% in RA
The high prevalence of thyroid nodules in people who underwent thyroid US at a health checkup suggests that increased detection of thyroid nodules resulted in an increased prevalence in the general population. However, metabolic disturbances may also have contributed to the increase in thyroid nodule prevalence in Korea.
Increased detection of thyroid nodules using high-resolution ultrasonography has resulted in a world-wide increase in the incidence of differentiated thyroid cancer (DTC). Despite the steep increase in its incidence, the age-standardized mortality rate of thyroid cancer has remained stable, which leads toward a trend of more conservative treatment. The latest American Thyroid Association (ATA) guidelines for thyroid nodules and thyroid cancer revised in 2015 suggested that fine needle aspiration
BACKGROUND: Distant metastasis, generally to lung and bone, is rare in differentiated thyroid carcinoma (DTC) and the prognosis is still elusive. We investigated long-term outcomes of lung metastasis in DTC patients and its prognostic factors. METHODS: A retrospective review was performed of 4572 patients who underwent surgery for DTC from 1962 to 2009 at Seoul National University Hospital. Among them, 164 patients were identified with lung metastasis and 152 patients were enrolled in the final
, (5-10%) . 10 , .
, (5~10%) . 10 , . ,
. . (82.7%), (13.3%), (3.5%), (0.5%) . 1) (thyroid stimulating hormone, TSH) , .
A second course of ATD can be considered for GD patients after the first relapse because the chance of remission and the relapse rate are similar to the one after the first ATD treatment course. For GD patients with more than two relapses, or with an ATD treatment duration of more than four to five years, low-dose maintenance of ATD or ablative treatment needs to be considered.
Thyroid cancer is the most common malignancy in Korea; in 2012, about 44,000 new cases (19.6% of all malignancies) were registered and the estimated age-standardized incidence rate of thyroid cancer was 73.6 per 100,000 (17.3 and 88.6 per 100,000 in men and women, respectively). Despite the steep increase in its incidence, the age-standardized mortality rate of thyroid cancer has remained stable and 10-year relative survival rate is 99.2%. Increased detection using high-resolution ultrasonograph
. 10% 20-30% . T4 T3 50% 50% .
The aim of this study was to evaluate preoperatively identifiable clinical and ultrasonographic characteristics associated with central lymph node metastasis (CLNM) in clinically node negative papillary thyroid carcinoma (PTC) patients. Records of the patients who underwent thyroidectomy with prophylactic central lymph node dissection due to clinically node negative PTC (size, 1.0-3.0 cm) were reviewed. Of a total of 174 patients, 71 (40.8%) had CLNMs. CLNM was more associated with capsule invas
BACKGRUOUND: This study aimed to investigate the changes of incidence and treatment of choice for hyperthyroidism from 2003 to 2018 and explore the treatment-related complications and concomitant comorbidities in South Korea using data from the National Health Insurance Service. METHODS: This is a retrospective observational study. Hyperthyroidism was defined as a case having two or more diagnostic codes of thyrotoxicosis, with antithyroid drug intake for more than 6 months. RESULTS: The average
갑상선결절은 매우 흔하며, 그 임상적 중요성은 결절의 일 부(5~10%)가 갑상선암이라는 사실에 근거한다. 최근 10여 년간 갑상선결절 및 갑상선 분화암의 진단과 치료 분야에서 많은 발전이 있었으며, 갑상선결절 또는 갑상선암의 치료 권 고 안들이 여러 차례 발표된 바 있었다. 그러나 발표된 치료 권고안들 간에도 상충되는 내용이 있고, 아직 임상적으로나 보건의료학적 관점에서 논란이 되는 사항들이 많은 실정이 다. 대한내분비학회 갑상선분과회에서는 갑상선결절 및 갑 상선암 환자의 진료에 종사하는 여러 분야의 의사들에게 도 움을 주고자 2007년 “갑 상선결절 및 암 진료권고안”을 제 정하였다. 이 진료 권고안은 국내 주요 의료기관들에서 갑 상선질환 환자를 진료하고 있는 대한내분비학회 회원인 내 Special Contribution Korean J Otorhinolaryngol-Head Neck Surg 2011;54:8-36 / DOI 10.3342/kjorl-hns.2011.54.1.8
대표 연구 분야
이가희 교수의 연구를 Nubint에서 더 깊이 살펴보세요
이 연구실의 논문을 앱에서 열어 AI와 함께 읽고, 핵심을 요약하고, 내 글에 인용하세요.